Serochem成立于2019年，其目标是使基因治疗和生物制剂负担得起。用于治疗应用的原材料和试剂的价格不断上涨，使得研究和商业生产变得非常昂贵。我们正在努力通过设计高效的制造方法和可以轻松集成到客户流程中的新型材料来扭转这一趋势。

虽然我们最初的重点是基因治疗和生物制剂，但我们的合成化学专业知识适用于任何必须从头开始设计材料的行业，或者大型制造商无法满足所需的质量和一致性的行业。这种专注使我们成为医疗和高复杂工业应用的理想合作伙伴。 

我们通过三种方式帮助客户。首先，我们正在构建一系列具有成本效益的产品组合，以提供卓越的性能。我们基于PEI的瞬时转染试剂于2020年推出，我们正在努力在生物工艺领域增加更多产品。我们还为了解目标材料并需要设计和制造帮助的客户提供合同制造服务。最后，我们利用我们广泛的化工行业经验，为希望通过产品开发、营销或销售实现增长的公司提供咨询服务。

Serochem was founded in 2019 with the goal of making gene therapy and biologics affordable. Prices of raw materials and reagents used in therapeutic applications are continuously increasing, making research and commercial manufacturing prohibitively expensive. We're working to reverse the trend by designing efficient manufacturing methods and novel materials that can be easily integrated into our customers' processes.

While our initial focus is gene therapy and biologics, our synthetic chemistry expertise is applicable to any industry where a material must be designed from the ground up, or where large-scale manufacturers fail to meet the quality and consistency required. This focus makes us an ideal partner for medical and high complexity industrial applications. 

We help our clients in three ways. First, we're building a portfolio of cost-effective products that will give superior performance. Our PEI based transient transfection reagents launched in 2020 and we are working to add additional products in the bioprocessing space. We also provide contract manufacturing services for clients who know their target material and need help with design and manufacturing. Finally, we use our broad chemical industry experience to provide consulting services for companies that are looking to grow through product development, marketing, or sales.

Serochem常卖产品：

靶点科技（北京）有限公司是Serochem在中国的代理。被授权在中国负责品牌宣传推广，产品售前咨询和售后服务等一切商业活动和行为。靶点科技有专业技术团队，竭力为广大中国客户提供全方位的产品和服务赋能支持。

Serochem官网产品中文网站：筹备中……

Serochem官网英文网站：www.serochem.com